abstract |
The present invention relates to heterocyclic antibacterial agents with antimicrobial activity, and particularly, antibacterial activity against both sensitive and resistant strains, represented by general formula (1), or a pharmaceutically acceptable salt and/or prodrug thereof, wherein each of A and B independently represent fused rings selected from a group consisting of monocyclic or polycyclic cycloalkyls, cycloalkenyls, aryls, and heterocyclic rings, said rings comprising from 4 to 8 atoms in a ring structure: X represents CR, N, N(O), P, or As; Y represents CR2, NR, O, PR, S, AsR, or Se. |